Topics in Drug Testing from Quest Diagnostics

Topics in Drug Testing from Quest Diagnostics header image 1

Alternative Specimen Collection Options

ep11-twitter.png

Today’s podcast discussion will focus on the importance of drug monitoring and the benefits of “alternative” sample collection options during the COVID-19 pandemic. Key information shared will include:

  • How clinical drug monitoring is a critical tool to help assess prescription compliance with controlled substances and help identify drug misuse
  • Situations, including the COVID-19 pandemic, when in-office collection isn't always possible
  • Quest Diagnostics’ offerings for alternative specimen collection options, including:
    - Self /At-Home collection
    - Patient Service Center collection
  • How alternative collection options can help ensure your patients get the testing they need

The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin, and Jason Suomala, Senior Product Manager for the Quest Diagnostics Drug Monitoring and Toxicology division.

You may download a PDF version of this presentation here >>

To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

The epidemic within the pandemic

quest-ep10-twitter.png

Today’s podcast will share results of a recent Quest Diagnostics Health Trends™ publication, The Opioid Epidemic Within the COVID-19 Pandemic: Drug Monitoring in 2020, which was published in the October 2020 edition of Population Health Management. The study objective was to better understand the relationship between the COVID-19 pandemic and the drug epidemic in the US. To achieve this objective, investigators analyzed urine specimen results from an analytic cohort of 872,762 specimens from all 50 states and the District of Columbia. Findings demonstrated significant changes in prescription drug monitoring and positivity rates for many drugs of concern. Important study results and conclusions discussed will include:

  • Clinical drug testing decreased significantly during the pandemic period
  • Nonprescribed positivity for fentanyl, heroin, and other drugs of concern increased significantly
  • Many dangerous drug combinations, including combinations with fentanyl,  increased significantly
  • The impact of the COVID-19 pandemic on the treatment of patients at risk for substance use disorder
  • The role of clinical drug monitoring

This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™.

You may download a PDF version of this presentation here >>

 

USmpBCvaHMuAYqilOKsr

WLfNVWbRhVQGbIYBnOir

Drug testing for stimulants

Quest episode 9 Drug testing for stimulants

Today’s podcast will cover drug testing for stimulants and will highlight some of the challenges in results interpretation for this class of drugs. Important information shared during the discussion will include:

  • What is classified as a stimulant
  • Analysis of Amphetamine, Methamphetamine, and MDMA
  • Interpretation challenges
  • Synthetic stimulants
  • The role of clinical drug monitoring
  • Quest Diagnostics amphetamine drug testing offering

 

The episode features Dr Les Edinboro, PhD, executive science director, and Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology.

 

You may download a PDF version of this presentation here >>

 

To listen to other podcasts in our “Topics in Drug Testing” series, or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.

Drug Monitoring in Behavioral Health and during times of crisis

Quest-Drug monitoring in times of crisis

Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include:

  • Mental Health disorders, diagnosis and prevalence
  • The challenge of medication adherence in mental health treatment
  • The impact of crises on the treatment of patients with mental health conditions
  • The role of clinical drug monitoring

 

The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division.

 

You may download a PDF version of this presentation here >>

 

To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Drug Misuse in America

quest-ep7-tweet-drugmisuse.png

Today’s podcast will cover key findings from the annual Quest Diagnostics Health Trends report, Drug Misuse in America. Some of the key topics shared will include:

  • Summary of analysis of more than 4.4 million de-identified drug monitoring tests performed by Quest Diagnostics from 2011 through 2018
  • Findings of a Harris Poll survey of 500 primary care physicians, as part of Health Trends report analysis
  • Highlights of the evolving drug misuse crisis in America, including Drug mixing and the overdose death connection
  • Key challenges facing physicians today, with regards to identifying drug misuse, and treating patients with chronic pain
  • The role and importance of drug monitoring and incorporating it into medical practice

This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™. 

You may download a PDF version of this presentation here>>

To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Kratom: Identifying “a drug of concern”

quest-ep6-tweet-kratom.png

Today’s podcast will cover testing for kratom, a drug of concern. Some of the key information shared will include:

  • What is kratom?
    • What is the chemical make-up?
  • Kratom toxicity and side effects
  • Testing for kratom
    • Why testing is important?
    • How to test for kratom
    • What testing will tell you

This episode features Jack Kain, PharmD, Quest Diagnostics medical science liaison, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. 

You may download a PDF version of this presentation here>>

To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Dangerous drug combinations

quest-ep4-twitter.png

 

Today’s podcast will cover dangerous drug combinations and the role of clinical drug monitoring. Some of the key information that will be shared includes:

  • What are dangerous drug combinations
  • What practitioners and the public need to know about them
  • How dangerous drug combinations can work together to lead to side effects
    • Certain combinations predispose people to a greater risk of overdose and death
    • Combinations that can affect drug levels, creating a pharmacokinetic drug–drug interaction
    • Certain combinations that may result in excessive sedation
  • How drug testing can help
    • A tool to identify dangerous drug combinations
    • How drug testing identifies metabolites unique to a substance

This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. 

You may download the PDF version of this presentation here>>

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Screening for alcohol use in pain management and primary care: it’s about time

quest-ep3-tweet.png

The podcast will cover screening (drug testing) for alcohol use in pain management and primary care. Topics covered will include:

  • Understand drug and alcohol misuse and abuse
    • Prevalence rates of alcohol use and misuse, and alcohol use disorders
    • Information on alcohol use, and concomitant use with opioids and benzodiazepines
  • Screening guidelines
    • Tools and types of tests
  • Testing for alcohol
    • Breathalyzer
    • Advances in testing
    • Biomarkers
    • Other considerations
    • Quest Diagnostics approach

This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. 

You may download the PDF version of this presentation here>>

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Patients with substance use disorders in medication-assisted treatment (MAT)

Today’s episode is on patients with substance use disorders in medication-assisted treatment (MAT). Some of the key points that will be covered include:

  • What is medication-assisted treatment
  • What are the goals of an MAT treatment program
  • Medications used in MAT treatment 
  • Drug testing during MAT
    • Purpose of drug testing
    • Types of drug testing
      • Specimen collection
      • Specimen validity
    • Test confirmation

This episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. 

You may download the PDF version of this presentation here >

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Drug testing your patients for marijuana

1200x675_quest-ep1-thc.png

Today, we will be talking about marijuana and marijuana-based products in order to: 

  • Understand drug testing for marijuana, and why it’s important
  • Examine marijuana used in concert with controlled medications for pain or ADHD
  • Give some general recommendations for therapeutic drug monitoring for marijuana in patients with chronic pain using controlled substances
    • For example, at a minimum such patients should be tested before opioid therapy begins, again within 1 to 3 months, and randomly over the next 12 months, and more frequently if there are unexpected results, or there are complaints or behavior changes in the patient 

The episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. They will be discussing drug testing your patients for marijuana.

You may download the PDF version of this presentation here >

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Podbean App

Play this podcast on Podbean App